To further assess Fbxo4–Fxr1 regulation in tumorigenesis, tumours that developed in Fbxo4 + / + , + /− and −/− mice, treated with N-nitrosomethylbenzylamine (NMBA) to trigger SCC23–25, were subjected to IHC staining. This evidence concerns the gene FXR1 and neoplasm.